HOSPIRA INC, LAKE FOREST recalls Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-…

Recall date

July 26, 2017

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1082-2017

FDA classification

Class II

Brand / firm

HOSPIRA INC, LAKE FOREST

Sold / distributed

Nationwide in the USA

Why it was recalled

Presence of Particulate Matter: Silicone oil

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA.